ANDIRA

Andira is a private pharmaceutical technology company commercializing breakthrough advancements for infection control and other high unmet need healthcare indications... Andira is targeting near-term market approval of Matrix3™ Shield for surgical site infection (SSI), an advanced wound care medical device demonstrating over 1,000,000 X improved anti-bacterial performance versus the standard-of-care. With medical research indicating current infection control products lack efficacy, coupled with increasing antimicrobial resistance, the need for improved infection control in healthcare settings is at an all-time high... Andira's lead product line for infection control is Matrix3™ Shield, an anti-infective medical device for advanced wound care. The underlying breakthrough technology is Matrix3™, a triple synergy silver-based antibiotic, shown to have over 1,000,000 times improved anti-bacterial efficacy versus conventional antimicrobial silver. Silver-based medical devices, wound..